Moneycontrol PRO
HomeNewsHind rectifiers

Hind Rectifiers

Jump to
  • Hind Rectifiers acquires France-based BeLink in major boost to global footprint, shares locked at 5 percent upper circuit

    The acquisition helps establish a European base for EMS, Robotics and Power Electronics manufacturing for Hind Rectifiers, along with a 'strategic manufacturing base' in Europe.

  • Hind Rectifiers Standalone June 2025 Net Sales at Rs 214.77 crore, up 58.47% Y-o-Y

    Hind Rectifiers Standalone June 2025 Net Sales at Rs 214.77 crore, up 58.47% Y-o-Y

  • Hind Rectifiers Consolidated June 2025 Net Sales at Rs 214.77 crore, up 58.47% Y-o-Y

    Hind Rectifiers Consolidated June 2025 Net Sales at Rs 214.77 crore, up 58.47% Y-o-Y

  • Stocks to Watch Today: Torrent Pharma, JB Chemicals, Jyoti CNC, BHEL, Alembic Pharma, Waaree Energies, Prestige Estates, Hind Rectifiers in focus on 30 June

    Stocks to Watch Today: Torrent Pharma, JB Chemicals, Jyoti CNC, BHEL, Alembic Pharma, Waaree Energies, Prestige Estates, Hind Rectifiers in focus on 30 June

    Stocks to Watch, 30 June: Stocks like Torrent Pharmaceuticals, JB Chemicals and Pharmaceuticals, Jyoti CNC Automation, BHEL, Alembic Pharma, Waaree Energies, Prestige Estates Projects, Bharti Airtel, Le Lavoir, Reliance Industries, and Hind Rectifiers will be in focus on June 30.

  • Hind Rectifiers Consolidated March 2025 Net Sales at Rs 185.05 crore, up 22.26% Y-o-Y

    Hind Rectifiers Consolidated March 2025 Net Sales at Rs 185.05 crore, up 22.26% Y-o-Y

  • Hind Rectifiers Standalone March 2025 Net Sales at Rs 185.05 crore, up 22.26% Y-o-Y

    Hind Rectifiers Standalone March 2025 Net Sales at Rs 185.05 crore, up 22.26% Y-o-Y

  • Stocks to Watch Today: Indian Hotels, CCL Products, DCM Shriram, Ather Energy, Senores Pharma, Paras Defence, Glenmark in focus on 6 May

    Stocks to Watch Today: Indian Hotels, CCL Products, DCM Shriram, Ather Energy, Senores Pharma, Paras Defence, Glenmark in focus on 6 May

    Stocks to Watch, 06 May: Stocks like Computer Age Management Services, Bombay Dyeing & Manufacturing Company, Zee Media Corporation, Jammu & Kashmir Bank, Prataap Snacks, Hind Rectifiers, Cigniti Technologies, Coforge, Indian Energy Exchange, Paras Defence and Space Technologies, and IRCON International will be in focus on May 6.

  • Hind Rectifiers Consolidated December 2024 Net Sales at Rs 168.94 crore, up 23.65% Y-o-Y

    Hind Rectifiers Consolidated December 2024 Net Sales at Rs 168.94 crore, up 23.65% Y-o-Y

  • Hind Rectifiers Standalone December 2024 Net Sales at Rs 168.94 crore, up 23.65% Y-o-Y

    Hind Rectifiers Standalone December 2024 Net Sales at Rs 168.94 crore, up 23.65% Y-o-Y

  • Hind Rectifiers Standalone September 2024 Net Sales at Rs 165.84 crore, up 25.66% Y-o-Y

    Hind Rectifiers Standalone September 2024 Net Sales at Rs 165.84 crore, up 25.66% Y-o-Y

  • Hind Rectifiers stock soars to 10% upper circuit on spurt in volumes

    Hind Rectifiers stock soars to 10% upper circuit on spurt in volumes

    Hind Rectifiers specialises in the development, design, manufacturing and marketing of power semiconductors, electronic equipment, and railway transportation equipment.

  • Hind Rectifiers stock locked at 5% upper circuit on Rs 200 crore order from Indian Railways

    Hind Rectifiers stock locked at 5% upper circuit on Rs 200 crore order from Indian Railways

    Hind Rectifiers' shares surged 5 percent to hit the upper circuit on September 23 after securing a Rs 200 crore supply order from Indian Railways, boosting investor sentiment.

  • Hind Rectifiers Standalone June 2024 Net Sales at Rs 135.53 crore, up 38.88% Y-o-Y

    Hind Rectifiers Standalone June 2024 Net Sales at Rs 135.53 crore, up 38.88% Y-o-Y

  • Hind Rectifiers Standalone March 2024 Net Sales at Rs 151.36 crore, up 35.64% Y-o-Y

    Hind Rectifiers Standalone March 2024 Net Sales at Rs 151.36 crore, up 35.64% Y-o-Y

  • Hind Rectifiers Standalone December 2023 Net Sales at Rs 136.63 crore, up 40.52% Y-o-Y

    Hind Rectifiers Standalone December 2023 Net Sales at Rs 136.63 crore, up 40.52% Y-o-Y

  • Hind Rectifiers Standalone September 2023 Net Sales at Rs 131.98 crore, up 69.99% Y-o-Y

    Hind Rectifiers Standalone September 2023 Net Sales at Rs 131.98 crore, up 69.99% Y-o-Y

  • Hind Rectifiers Standalone June 2023 Net Sales at Rs 97.58 crore, up 34.34% Y-o-Y

    Hind Rectifiers Standalone June 2023 Net Sales at Rs 97.58 crore, up 34.34% Y-o-Y

  • Hind Rectifiers Standalone March 2023 Net Sales at Rs 111.59 crore, up 9.03% Y-o-Y

    Hind Rectifiers Standalone March 2023 Net Sales at Rs 111.59 crore, up 9.03% Y-o-Y

  • Hind Rectifiers jumps 15% as Sinnar plant goes on stream

    Hind Rectifiers jumps 15% as Sinnar plant goes on stream

    The share price of Hind Rectifiers gained 15 percent after the company commenced commercial production at new manufacturing plant at Sinnar.

  • Hind Rectifiers Standalone December 2022 Net Sales at Rs 97.23 crore, up 3.24% Y-o-Y

    Hind Rectifiers Standalone December 2022 Net Sales at Rs 97.23 crore, up 3.24% Y-o-Y

  • Hind Rectifiers Standalone June 2022 Net Sales at Rs 72.64 crore, down 1.1% Y-o-Y

    Hind Rectifiers Standalone June 2022 Net Sales at Rs 72.64 crore, down 1.1% Y-o-Y

  • Hind Rectifiers Standalone March 2022 Net Sales at Rs 102.34 crore, up 35.43% Y-o-Y

    Hind Rectifiers Standalone March 2022 Net Sales at Rs 102.34 crore, up 35.43% Y-o-Y

  • Hind Rectifiers Standalone September 2021 Net Sales at Rs 102.12 crore, up 1.2% Y-o-Y

    Hind Rectifiers Standalone September 2021 Net Sales at Rs 102.12 crore, up 1.2% Y-o-Y

  • Hind Rectifiers share price at 52-week high after Cassini Partners LP buys stake

    Hind Rectifiers share price at 52-week high after Cassini Partners LP buys stake

    The share price added 30 percent in the last three days and gained 45 percent in the last year.

  • Bulk Deals | Rakesh Jhunjhunwala buys 0.3% stake in Jubilant Pharmova

    Bulk Deals | Rakesh Jhunjhunwala buys 0.3% stake in Jubilant Pharmova

    As per the shareholding pattern of June 2021, Rakesh Radheshyam Jhunjhunwala held in total 6.29 percent stake in Jubilant Pharmova.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347